Testing of patients at three academic cancer centers in the U.S. did not yield a single case of undiagnosed HIV infection.
Since 2006, the CDC has recommended routine, opt-out HIV testing in healthcare settings for all individuals aged 13 to 64. Investigators recently performed HIV testing at three oncology clinics in the U.S. to determine the prevalence of undiagnosed HIV infection among patients with non–AIDS-defining cancers.
The 634 patients tested had a mean age of 53.2. Most were women (59.2%), white (76.5%), and insured (60.9% private, 20.1% Medicare), and most (51.3%) had never been tested for HIV. The most common malignancies among study participants were breast cancer (19.7%), colon cancer (10.3%), and melanoma (9.7%). None of the patients tested positive for HIV, for an estimated HIV prevalence of <0.3%.
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)